share_log

Benchmark Maintains Buy on Nutex Health, Lowers Price Target to $1.5

Benzinga ·  Nov 14, 2023 09:16

Benchmark analyst Bill Sutherland maintains Nutex Health (NASDAQ:NUTX) with a Buy and lowers the price target from $2.5 to $1.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment